Replimune Group Inc.

NASDAQ: REPL · Real-Time Price · USD
5.55
0.20 (3.74%)
At close: Aug 15, 2025, 3:59 PM
5.56
0.09%
After-hours: Aug 15, 2025, 04:10 PM EDT

Replimune Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a
Cost of Revenue
3.5M 2.65M 2.45M 4.58M 4.14M
Gross Profit
-3.5M -2.65M -2.45M -4.58M -4.14M
Operating Income
-261.63M -234.77M -177.08M -118.31M -79.95M
Interest Income
21.12M 23.36M 10.01M 390K 916K
Pretax Income
-246.83M -215.39M -174M -118.04M -80.87M
Net Income
-247.3M -215.79M -174.28M -118.04M -80.87M
Selling & General & Admin
72.18M 59.81M 50.55M 38.77M 23.2M
Research & Development
189.45M 174.96M 126.53M 79.55M 56.75M
Other Expenses
n/a n/a n/a n/a n/a
Operating Expenses
261.63M 234.77M 177.08M 118.31M 79.95M
Interest Expense
7.89M 6.66M 4.16M 2.22M 3.06M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a
Cost & Expenses
261.63M 234.77M 177.08M 118.31M 79.95M
Income Tax Expense
468K 408K 288K n/a n/a
Shares Outstanding (Basic)
80.56M 66.57M 58.21M 52.21M 46.25M
Shares Outstanding (Diluted)
80.56M 66.57M 58.21M 52.21M 46.25M
EPS (Basic)
-3.07 -3.24 -2.99 -2.26 -1.75
EPS (Diluted)
-3.07 -3.24 -2.99 -2.26 -1.75
EBITDA
-261.63M -230.2M -170.3M -114.41M -76.48M
EBIT
-240.71M -232.85M -172.75M -118.98M -80.62M
Depreciation & Amortization
3.5M 2.65M 2.45M 4.58M 4.14M